Publications found:
55,654
Sort by:
Overactive Bladder R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OVERACTIVE BLADDER PIPELINE REPORT INCLUDES Panorama of Overactive Bladder pipeline markets including statistics on therapeutic drugs and companies involved Overactive Bladder Pipeline candidates across various development ...
August 2018
90 pages
Pancreatic Ductal Adenocarcinoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PANCREATIC DUCTAL ADENOCARCINOMA PIPELINE REPORT INCLUDES Panorama of Pancreatic Ductal Adenocarcinoma pipeline markets including statistics on therapeutic drugs and companies involved Pancreatic Ductal Adenocarcinoma Pipeline candidates across various development ...
August 2018
200 pages
Pancreatitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PANCREATITIS PIPELINE REPORT INCLUDES Panorama of Pancreatitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Papillary Thyroid Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PAPILLARY THYROID CANCER PIPELINE REPORT INCLUDES Panorama of Papillary Thyroid Cancer pipeline markets including statistics on therapeutic drugs and companies involved Papillary Thyroid Cancer Pipeline candidates across various development ...
August 2018
60 pages
Paroxysmal Nocturnal Hemoglobinuria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PIPELINE REPORT INCLUDES Panorama of Paroxysmal Nocturnal Hemoglobinuria pipeline markets including statistics on therapeutic drugs and companies involved Paroxysmal Nocturnal Hemoglobinuria Pipeline candidates across various development ...
August 2018
80 pages
Peanut Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PEANUT ALLERGY PIPELINE REPORT INCLUDES Panorama of Peanut Allergy pipeline markets including statistics on therapeutic drugs and companies involved Peanut Allergy Pipeline candidates across various development ...
August 2018
90 pages
Pemphigus Vulgaris R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PEMPHIGUS VULGARIS PIPELINE REPORT INCLUDES Panorama of Pemphigus Vulgaris pipeline markets including statistics on therapeutic drugs and companies involved Pemphigus Vulgaris Pipeline candidates across various development ...
August 2018
50 pages
Peptic Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PEPTIC ULCERS PIPELINE REPORT INCLUDES Panorama of Peptic Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Peptic Ulcers Pipeline candidates across various development ...
August 2018
40 pages
Periodontitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PERIODONTITIS PIPELINE REPORT INCLUDES Panorama of Periodontitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... use format. SCOPE OF PERIPHERAL NERVE SHEATH TUMOR (NEUROFIBROSARCOMA) PIPELINE REPORT INCLUDES Panorama of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) pipeline markets including statistics on therapeutic drugs and companies involved Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline candidates ...
August 2018
120 pages
Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Peripheral Neuropathy Pipeline candidates across various development ...
August 2018
50 pages
Peripheral T Cell Lymphomas (PTCL) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF PERIPHERAL T CELL LYMPHOMAS (PTCL) PIPELINE REPORT INCLUDES Panorama of Peripheral T Cell Lymphomas (PTCL) pipeline markets including statistics on therapeutic drugs and companies involved Peripheral T Cell Lymphomas (PTCL) Pipeline candidates across ...
August 2018
200 pages
Peritonitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PERITONITIS PIPELINE REPORT INCLUDES Panorama of Peritonitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Pertussis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PERTUSSIS PIPELINE REPORT INCLUDES Panorama of Pertussis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
Phenylketonuria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PHENYLKETONURIA PIPELINE REPORT INCLUDES Panorama of Phenylketonuria pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Pheochromocytoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PHEOCHROMOCYTOMA PIPELINE REPORT INCLUDES Panorama of Pheochromocytoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Pigmented Villonodular Synovitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PIGMENTED VILLONODULAR SYNOVITIS PIPELINE REPORT INCLUDES Panorama of Pigmented Villonodular Synovitis pipeline markets including statistics on therapeutic drugs and companies involved Pigmented Villonodular Synovitis Pipeline candidates across various development ...
August 2018
40 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... use format. SCOPE OF PITUITARY ACTH HYPERSECRETION (CUSHING'S DISEASE) PIPELINE REPORT INCLUDES Panorama of Pituitary ACTH Hypersecretion (Cushing's Disease) pipeline markets including statistics on therapeutic drugs and companies involved Pituitary ACTH Hypersecretion (Cushing's Disease) Pipeline candidates ...
August 2018
40 pages
Plague Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PLAGUE DISEASE PIPELINE REPORT INCLUDES Panorama of Plague Disease pipeline markets including statistics on therapeutic drugs and companies involved Plague Disease Pipeline candidates across various development ...
August 2018
60 pages
Poliomyelitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF POLIOMYELITIS PIPELINE REPORT INCLUDES Panorama of Poliomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Polyarticular Juvenile Idiopathic Arthritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS PIPELINE REPORT INCLUDES Panorama of Polyarticular Juvenile Idiopathic Arthritis pipeline markets including statistics on therapeutic drugs and companies involved Polyarticular Juvenile Idiopathic Arthritis Pipeline candidates across ...
August 2018
60 pages
Polycystic Kidney Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POLYCYSTIC KIDNEY DISEASE PIPELINE REPORT INCLUDES Panorama of Polycystic Kidney Disease pipeline markets including statistics on therapeutic drugs and companies involved Polycystic Kidney Disease Pipeline candidates across various development ...
August 2018
90 pages
Polycystic Ovarian Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POLYCYSTIC OVARIAN SYNDROME PIPELINE REPORT INCLUDES Panorama of Polycystic Ovarian Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Polycystic Ovarian Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Polycythemia Vera R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POLYCYTHEMIA VERA PIPELINE REPORT INCLUDES Panorama of Polycythemia Vera pipeline markets including statistics on therapeutic drugs and companies involved Polycythemia Vera Pipeline candidates across various development ...
August 2018
70 pages
Pompe Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POMPE DISEASE PIPELINE REPORT INCLUDES Panorama of Pompe Disease pipeline markets including statistics on therapeutic drugs and companies involved Pompe Disease Pipeline candidates across various development ...
August 2018
60 pages
Pontine Glioma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PONTINE GLIOMA PIPELINE REPORT INCLUDES Panorama of Pontine Glioma pipeline markets including statistics on therapeutic drugs and companies involved Pontine Glioma Pipeline candidates across various development ...
August 2018
210 pages
Portal Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PORTAL HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Portal Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Portal Hypertension Pipeline candidates across various development ...
August 2018
60 pages
Post Menopausal Osteoporosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POST MENOPAUSAL OSTEOPOROSIS PIPELINE REPORT INCLUDES Panorama of Post Menopausal Osteoporosis pipeline markets including statistics on therapeutic drugs and companies involved Post Menopausal Osteoporosis Pipeline candidates across various development ...
August 2018
70 pages
Post Polycythemia Vera Myelofibrosis (PPV MF) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF POST POLYCYTHEMIA VERA MYELOFIBROSIS (PPV MF) PIPELINE REPORT INCLUDES Panorama of Post Polycythemia Vera Myelofibrosis (PPV MF) pipeline markets including statistics on therapeutic drugs and companies involved Post Polycythemia Vera Myelofibrosis (PPV MF) Pipeline candidates across ...
August 2018
180 pages
Post Traumatic Stress Disorder R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF POST TRAUMATIC STRESS DISORDER PIPELINE REPORT INCLUDES Panorama of Post Traumatic Stress Disorder pipeline markets including statistics on therapeutic drugs and companies involved Post Traumatic Stress Disorder Pipeline candidates across ...
August 2018
100 pages
Postherpetic Neuralgia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POSTHERPETIC NEURALGIA PIPELINE REPORT INCLUDES Panorama of Postherpetic Neuralgia pipeline markets including statistics on therapeutic drugs and companies involved Postherpetic Neuralgia Pipeline candidates across various development ...
August 2018
80 pages
Poxviridae Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF POXVIRIDAE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Poxviridae Infections pipeline markets including statistics on therapeutic drugs and companies involved Poxviridae Infections Pipeline candidates across various development ...
August 2018
80 pages
Prader Willi Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRADER WILLI SYNDROME PIPELINE REPORT INCLUDES Panorama of Prader Willi Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Prader Willi Syndrome Pipeline candidates across various development ...
August 2018
70 pages
Pre Eclampsia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRE ECLAMPSIA PIPELINE REPORT INCLUDES Panorama of Pre Eclampsia pipeline markets including statistics on therapeutic drugs and companies involved Pre Eclampsia Pipeline candidates across various development ...
August 2018
50 pages
Premature Ejaculation R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PREMATURE EJACULATION PIPELINE REPORT INCLUDES Panorama of Premature Ejaculation pipeline markets including statistics on therapeutic drugs and companies involved Premature Ejaculation Pipeline candidates across various development ...
August 2018
40 pages
Premature Labor (Tocolysis) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PREMATURE LABOR (TOCOLYSIS) PIPELINE REPORT INCLUDES Panorama of Premature Labor (Tocolysis) pipeline markets including statistics on therapeutic drugs and companies involved Premature Labor (Tocolysis) Pipeline candidates across various development ...
August 2018
40 pages
Premenstrual Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PREMENSTRUAL SYNDROME PIPELINE REPORT INCLUDES Panorama of Premenstrual Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Premenstrual Syndrome Pipeline candidates across various development ...
August 2018
30 pages
Presbyopia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PRESBYOPIA PIPELINE REPORT INCLUDES Panorama of Presbyopia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Pressure Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRESSURE ULCERS PIPELINE REPORT INCLUDES Panorama of Pressure Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Pressure Ulcers Pipeline candidates across various development ...
August 2018
30 pages
Primary Biliary Cirrhosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY BILIARY CIRRHOSIS PIPELINE REPORT INCLUDES Panorama of Primary Biliary Cirrhosis pipeline markets including statistics on therapeutic drugs and companies involved Primary Biliary Cirrhosis Pipeline candidates across various development ...
August 2018
90 pages
Primary Hyperoxaluria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY HYPEROXALURIA PIPELINE REPORT INCLUDES Panorama of Primary Hyperoxaluria pipeline markets including statistics on therapeutic drugs and companies involved Primary Hyperoxaluria Pipeline candidates across various development ...
August 2018
40 pages
Primary Immune Deficiency R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY IMMUNE DEFICIENCY PIPELINE REPORT INCLUDES Panorama of Primary Immune Deficiency pipeline markets including statistics on therapeutic drugs and companies involved Primary Immune Deficiency Pipeline candidates across various development ...
August 2018
70 pages
Primary Progressive Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Primary Progressive Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Primary Progressive Multiple Sclerosis Pipeline candidates across ...
August 2018
80 pages
Primary Sclerosing Cholangitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY SCLEROSING CHOLANGITIS PIPELINE REPORT INCLUDES Panorama of Primary Sclerosing Cholangitis pipeline markets including statistics on therapeutic drugs and companies involved Primary Sclerosing Cholangitis Pipeline candidates across various development ...
August 2018
80 pages
Progressive Multifocal Leukoencephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Progressive Multifocal Leukoencephalopathy pipeline markets including statistics on therapeutic drugs and companies involved Progressive Multifocal Leukoencephalopathy Pipeline candidates across various ...
August 2018
20 pages
Progressive Relapsing Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Progressive Relapsing Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Progressive Relapsing Multiple Sclerosis Pipeline candidates across ...
August 2018
30 pages
Progressive Supranuclear Palsy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROGRESSIVE SUPRANUCLEAR PALSY PIPELINE REPORT INCLUDES Panorama of Progressive Supranuclear Palsy pipeline markets including statistics on therapeutic drugs and companies involved Progressive Supranuclear Palsy Pipeline candidates across various development ...
August 2018
60 pages
Proliferative Diabetic Retinopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROLIFERATIVE DIABETIC RETINOPATHY PIPELINE REPORT INCLUDES Panorama of Proliferative Diabetic Retinopathy pipeline markets including statistics on therapeutic drugs and companies involved Proliferative Diabetic Retinopathy Pipeline candidates across various development ...
August 2018
40 pages
